Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ

dasiglucagon
$496.0060per ML

Strength

.6 mg/.6mL

Manufacturer

Zealand Pharma US, Inc

NDC

80644001201

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

4/17/2024

Active Ingredients

DASIGLUCAGON

Approval Type

New Drug (NDA)

FDA Application

NDA214231

On Market Since

4/5/2021

Pharmacological Classes

Antihypoglycemic Agent
Glucagon Receptor Agonists
Increased Glycogenolysis

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

N/A

Generic Alternatives

Save up to 1%

1 alternative • Same active ingredient

ZEGALOGUE 0.6 MG/0.6 ML AUTOINJ
Brand
00169191202•Novo Nordisk
$492.8315
Save 1%

Related Drugs

Same classification

BAQSIMI 3 MG SPRAY ONE PACK
Brand
00548835101•Amphastar Pharmaceuticals, Inc.
$293.3876
per EA
BAQSIMI 3 MG SPRAY TWO PACK
Brand
00548835202•Amphastar Pharmaceuticals, Inc.
$293.8325
per EA
GVOKE HYPOPEN 2-PK 1 MG/0.2 ML
Brand
72065012112•Xeris Pharmaceuticals, Inc.
$1600.0330
per ML
GVOKE HYPOPEN 1-PK 1 MG/0.2 ML
Brand
72065012111•Xeris Pharmaceuticals, Inc.
$1602.3028
per ML
GVOKE 1 MG/0.2 ML KIT
Brand
72065014011•Xeris Pharmaceuticals, Inc.
$1603.8017
per ML
GVOKE PFS 1-PK 1 MG/0.2 ML SYR
Brand
72065013111•Xeris Pharmaceuticals, Inc.
$1604.3171
per ML
GVOKE PFS 2-PK 1 MG/0.2 ML SYR
Brand
72065013112•Xeris Pharmaceuticals, Inc.
$1607.2875
per ML
GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML
Brand
72065012012•Xeris Pharmaceuticals, Inc.
$3205.3154
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy